Conference Dates: April 3-4, 2009
Conference Location: New York, NY
Sponsoring Group: Imedex
Conference Web Page URL: www.imedex.com/appweb/announcements/a046-01.asp
Conference Objectives: After attending this symposium, participants should be able to:
Who Should Attend: This educational activity is specifically designed for gastroenterologists, medical oncologists, radiation oncologists, hepatologists, surgeons, clinical researchers, and physicians-in-training who wish to review and update their knowledge and management of gastrointestinal malignancies.
Conference Agenda: This meeting is a different kind of educational event – one we know you will enjoy and learn from. Recognized thought leaders will engage in lively and interactive debates over some of the most controversial topics in the field and offer selected didactic presentations on the latest developments in colorectal cancer, GIST, pancreatic cancer, upper GI malignancies and more. Faculty and audience discussion will be encouraged with a focus on how new information fits into current community practice in the field, providing you with the opportunity to learn how experts in the field manage their patients.
Registration Information: Register online by Thursday, March 26, 2009 at www.imedex.com or by calling Imedex at +1 (678) 242 0906
Conference Fees: $150 physicians/$75 nurses
Continuing Education: Yes
Nov 26, 2012 - For patients with metastatic colorectal cancer or gastrointestinal stromal tumors who have progressed in spite of treatment, the multikinase inhibitor regorafenib may improve survival, according to the results of two phase 3 studies published online Nov. 22 in The Lancet.